Close
Nordic 9Nordic 9

XGEN Venture (investor - Venture Capital)

Italy xgenventure.com
See something wrong or missing? Let us know
Offices:Milano

XGEN Venture is an Italian investment company backing next generation life science ventures.

  • in 2024, XGEN Ventures announced raising €180 million for its debut fund
Average round investment:62.54M USD
Average number per year:2.3
Distribution: 2025 (3)2024 (3)2023 (1)
Portfolio companies: United Kingdom EpilepsyGTxItaly AAVantgarde BioItaly Nanophoria See the entire list
Mostly invests in: Italy Italy (4) Health services (7)
See the entire list

Showing 3 of 7 tracked investments in:

You need an account to access this feature. Log in or create one from here.

Do you have a question? Talk to us.

XGEN Venture mostly invests with:

You need an account to access this feature. Log in or create one from here.

Do you have a question? Talk to us.

Investors with similar profile to XGEN Venture

Name Criteria
Israel Pontifax Venture Capital
83%
  • Range for average deal size: 50M - 100M USD
  • Similar verticals: Health services, Biotech, Pharma, Manufacturing
  • Similar business models: B2B
  • Common investees countries: United Kingdom, Germany, Switzerland
  • Average number of deals per year: 2.3
  • Active last 12 months: Yes
Germany Athos Service
83%
  • Range for average deal size: 50M - 100M USD
  • Similar verticals: Health services, Biotech, Pharma, Manufacturing
  • Similar business models: B2B
  • Common investees countries: Germany, Switzerland
  • Average number of deals per year: 2.2
  • Active last 12 months: Yes
United States Cormorant Asset Management
83%
  • Range for average deal size: 50M - 100M USD
  • Similar verticals: Health services, Biotech, Pharma, Manufacturing
  • Similar business models: B2B
  • Common investees countries: Switzerland
  • Average number of deals per year: 2.0
  • Active last 12 months: Yes
United States Northpond Ventures
83%
  • Range for average deal size: 50M - 100M USD
  • Similar verticals: Health services, Biotech, Pharma, Manufacturing
  • Similar business models: B2B
  • Common investees countries: United Kingdom, Germany, Switzerland
  • Average number of deals per year: 2.0
  • Active last 12 months: Yes
France Mirova
83%
  • Range for average deal size: 50M - 100M USD
  • Similar verticals: Health services, Manufacturing, Hardware
  • Similar business models: B2B
  • Common investees countries: Germany
  • Average number of deals per year: 2.8
  • Active last 12 months: Yes
Belgium Fundplus
83%
  • Range for average deal size: 50M - 100M USD
  • Similar verticals: Health services, Biotech, Pharma, Manufacturing
  • Similar business models: B2B
  • Common investees countries: Germany
  • Average number of deals per year: 2.8
  • Active last 12 months: Yes
United States Bristol-Myers Squibb
83%
  • Range for average deal size: 50M - 100M USD
  • Similar verticals: Health services, Biotech, Pharma, Manufacturing
  • Similar business models: B2B
  • Common investees countries: United Kingdom, Germany
  • Average number of deals per year: 1.8
  • Active last 12 months: Yes
United States Versant Ventures
83%
  • Range for average deal size: 50M - 100M USD
  • Similar verticals: Health services, Biotech, Pharma, Manufacturing
  • Similar business models: B2B
  • Common investees countries: United Kingdom, Switzerland
  • Average number of deals per year: 1.8
  • Active last 12 months: Yes
Switzerland Roche Venture Fund
83%
  • Range for average deal size: 50M - 100M USD
  • Similar verticals: Health services, Biotech, Pharma, Manufacturing
  • Similar business models: B2B
  • Common investees countries: Italy, United Kingdom, Switzerland
  • Average number of deals per year: 1.7
  • Active last 12 months: Yes
United States Surveyor Capital
83%
  • Range for average deal size: 50M - 100M USD
  • Similar verticals: Health services, Biotech, Pharma, Manufacturing
  • Similar business models: B2B
  • Common investees countries: Germany, Switzerland
  • Average number of deals per year: 1.7
  • Active last 12 months: Yes
Top